Peptides and Peptidomimetics as antimicrobial therapeutic agents
Antibiotic resistance is currently a major public health challenge and one of the priorities of the World Health Organization. It is responsible for 750,000 deaths per year and is expected to increase to 10 million by 2050. This dramatic situation is leading scientists to search for new molecules with different structures and mode of action to overcome resistance. Lately, our laboratory has been successfully exploring different strategies to combat this resistance by identifying and characterizing new antimicrobials [1-4]. Among them, our group has demonstrated the potent activity of temporins (amphibian AMPs) and lynronnes (ruminal AMPs obtained by metagenomics approach) against various bacteria infecting humans (H. pylori, S. aureus, P. aeruginosa, …) and their safety toward human cells and tissues [5-9].
In this project, we intend to develop novel peptides and/or peptidomimetics based on the temporins and lynronnes families with the final goal of obtaining antimicrobial agents with higher activity and stability. Different derivatives will be produced containing diverse modifications (e.g. D-amino acids, non-proteinogenic amino acids, peptide backbone cyclization, peptoid building blocks, …) and their antimicrobial activity as well as their stability, mechanism of action and safety towards human cells will be studied. This is an interdisciplinary Ph.D. project covering fields as varied as peptide design, solution and solidphase peptide synthesis, organic synthesis, antimicrobial activity studies, toxicology and microbiology.
1. Chiumento et al., Sciences advances, 2019, 5, (10.1126/sciadv.aaw9969); 2. Roblin et al., Proc. Natl. Acad. Sci. U.S.A, 2020, 117, 19168.; 3. Hadiouch et al., Polym Chem. 2022, 13, 69; 4. Casanova et al., Antibiotics, 2023, 12, 120. 5. Olleik et al., Biomolecules, 2019, 9, 598. 6. Mulkern et al., Nature Biofilms Microbiomes, 2022, 8, 70; 7. Oyama et al., Nature Biofilms Microbiomes, 2022, 8, 58; 8. Khan et al., Biomolecules, 2022, 12, 770; 9. Maharjan et al., Probiotics Antimicrob Proteins. 2022, 14, 391.
Peptides, peptidomimetics, antimicrobial activity, cytotoxicity, microbial death mechanism
Profile and required skills
Master in chemistry or chemical engineering.
Background in organic and/or peptide synthesis. Knowledge in medicinal chemistry, drug design, toxicology and/or cells studies would be appreciated.
Candidates should send a CV, a motivation letter, transcripts of academic records and the contact information of two referees to:
Dr Olga Iranzo [email protected] & Dr Marc Maresca [email protected] Aix Marseille University, iSm2 CNRS UMR 7313, BiosCiences team
Application deadline: 30/04/2023
Download PDF version.